Epoch Investment Partners’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $241K | Buy |
+4,996
| New | +$233K | ﹤0.01% | 231 |
|
|
2023
Q2 | – | Sell |
-4,728
| Closed | -$257K | – | 459 |
|
|
2023
Q1 | $257K | Buy |
+4,728
| New | +$230K | ﹤0.01% | 425 |
|
|
2022
Q3 | – | Sell |
-4,391
| Closed | -$220K | – | 446 |
|
|
2022
Q2 | $220K | Sell |
4,391
-825
| -16% | -$43.8K | ﹤0.01% | 430 |
|
|
2022
Q1 | $268K | Sell |
5,216
-558
| -10% | -$28.8K | ﹤0.01% | 426 |
|
|
2021
Q4 | $289K | Buy |
5,774
+345
| +6% | +$17.1K | ﹤0.01% | 336 |
|
|
2021
Q3 | $262K | Sell |
5,429
-29
| -0.5% | -$1.48K | ﹤0.01% | 343 |
|
|
2021
Q2 | $287K | Sell |
5,458
-244
| -4% | -$12.7K | ﹤0.01% | 333 |
|
|
2021
Q1 | $282K | Sell |
5,702
-535
| -9% | -$25.7K | ﹤0.01% | 317 |
|
|
2020
Q4 | $303K | Buy |
6,237
+242
| +4% | +$11.9K | ﹤0.01% | 318 |
|
|
2020
Q3 | $301K | Sell |
5,995
-21
| -0.3% | -$1.08K | ﹤0.01% | 290 |
|
|
2020
Q2 | $307K | Sell |
6,016
-992
| -14% | -$48.2K | ﹤0.01% | 277 |
|
|
2020
Q1 | $306K | Sell |
7,008
-427
| -6% | -$20.4K | ﹤0.01% | 262 |
|
|
2019
Q4 | $373K | Sell |
7,435
-251
| -3% | -$11.8K | ﹤0.01% | 281 |
|
|
2019
Q3 | $356K | Sell |
7,686
-3,167
| -29% | -$137K | ﹤0.01% | 266 |
|
|
2019
Q2 | $470K | Buy |
10,853
+1,477
| +16% | +$62.8K | ﹤0.01% | 270 |
|
|
2019
Q1 | $415K | Buy |
9,376
+1,989
| +27% | +$85.2K | ﹤0.01% | 292 |
|
|
2018
Q4 | $321K | Sell |
7,387
-962
| -12% | -$42.4K | ﹤0.01% | 292 |
|
|
2018
Q3 | $373K | Sell |
8,349
-1,096
| -12% | -$46.8K | ﹤0.01% | 298 |
|
|
2018
Q2 | $378 | Sell |
9,445
-1,215
| -11% | -$47.8K | ﹤0.01% | 308 |
|
|
2018
Q1 | $427K | Sell |
10,660
-70
| -0.7% | -$2.91K | ﹤0.01% | 302 |
|
|
2017
Q4 | $461K | Sell |
10,730
-172
| -2% | -$7.93K | ﹤0.01% | 299 |
|
|
2017
Q3 | $543K | Sell |
10,902
-6
| -0.1% | -$290 | ﹤0.01% | 292 |
|
|
2017
Q2 | $523K | Sell |
10,908
-632
| -5% | -$30.2K | ﹤0.01% | 289 |
|
|
2017
Q1 | $522K | Sell |
11,540
-1,243
| -10% | -$52.7K | ﹤0.01% | 304 |
|
|
2016
Q4 | $517K | Sell |
12,783
-4,619
| -27% | -$182K | ﹤0.01% | 278 |
|
|
2016
Q3 | $665K | Buy |
17,402
+6,660
| +62% | +$267K | ﹤0.01% | 280 |
|
|
2016
Q2 | $450K | Buy |
10,742
+1,039
| +11% | +$42.6K | ﹤0.01% | 276 |
|
|
2016
Q1 | $390K | Buy |
9,703
+3
| +0% | +$121 | ﹤0.01% | 279 |
|
|
2015
Q4 | $414K | Sell |
9,700
-5,362
| -36% | -$247K | ﹤0.01% | 285 |
|
|
2015
Q3 | $715K | Sell |
15,062
-24,657
| -62% | -$1.26M | ﹤0.01% | 233 |
|
|
2015
Q2 | $1.97M | Sell |
39,719
-2,160
| -5% | -$109K | 0.01% | 210 |
|
|
2015
Q1 | $2.07M | Sell |
41,879
-33,464
| -44% | -$1.6M | 0.01% | 209 |
|
|
2014
Q4 | $3.44M | Buy |
75,343
+1,808
| +2% | +$87.7K | 0.01% | 210 |
|
|
2014
Q3 | $4.15M | Sell |
73,535
-4,355
| -6% | -$234K | 0.02% | 218 |
|
|
2014
Q2 | $4.14M | Buy |
77,890
+1,617
| +2% | +$85.8K | 0.02% | 227 |
|
|
2014
Q1 | $3.99M | Buy |
76,273
+42,733
| +127% | +$2.16M | 0.02% | 228 |
|
|
2013
Q4 | $1.8M | Sell |
33,540
-38,369
| -53% | -$1.98M | 0.01% | 235 |
|
|
2013
Q3 | $3.64M | Buy |
71,909
+2,906
| +4% | +$148K | 0.02% | 231 |
|
|
2013
Q2 | $3.55M | Buy |
+69,003
| New | +$3.68M | 0.02% | 217 |
|
Other funds holding SNY
MIP
Epoch Investment Partners's SNY Position: Q1 2026 in Review
Epoch Investment Partners opened a new position in Sanofi (SNY) in Q1 2026: 4,996 shares worth $241K. The stake represents ﹤0.01% of the portfolio and ranks #231 among its holdings. This is a return to the name: Epoch Investment Partners previously reported a position in SNY as recently as Q1 2023.
Epoch Investment Partners first reported a position in SNY in Q2 2013 and has held it in 39 quarters since. The position peaked at $4.15M in Q3 2014. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.
- Epoch Investment Partners held 4,996 shares of Sanofi worth $241K as of Q1 2026.
- Sanofi was a new Epoch Investment Partners position in Q1 2026.
- Sanofi made up ﹤0.01% of Epoch Investment Partners's portfolio in Q1 2026, its #231 holding.
- Epoch Investment Partners first reported a position in Sanofi in Q2 2013 and has held it in 39 quarters since.
- Epoch Investment Partners's Sanofi position peaked at $4.15M in Q3 2014.
- 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.
Based on Epoch Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.